CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights

PRINCETON, N.J., July 29, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report second quarter 2025 financial results and recent business highlights after the market close on Thursday, August 7, 2025.

Read more at prnewswire.com